Quagen Pharmaceuticals Llc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 35 Fairfield Pl, West Caldwell, New Jersey (NJ) 07006, United States (USA)
- Operations here
- manufacturepack
- FDA identifiers
- FEI 3012403297 · DUNS 081343942
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-04-17
- NAIDrug Quality Assurance2023-05-09
- VAIDrug Quality Assurance2020-10-26
Drugs this plant is listed as making
6 distinct drugs across 12 products name this site in their FDA label.
- acyclovirAryeh Pharma Corp
- Benztropine MesylateQuagen Pharmaceuticals Llc
- BUTALBITAL and ACETAMINOPHENQuagen Pharmaceuticals Llc
- Butalbital, Acetaminophen And CaffeineQuagen Pharmaceuticals Llc
- GlycopyrrolateQuagen Pharmaceuticals Llc
- LevetiracetamQuagen Pharmaceuticals Llc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.